Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03447275
Other study ID # EMR 200054-604
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2011
Est. completion date September 2011

Study information

Verified date May 2018
Source Saarland University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study was to evaluate vitamin B deficiency (particularly vitamin B6 deficiency) in diabetic patients in Germany in relation to the presence or absence of proteinuria, and global vascular risk.


Description:

This observational study recruited either control subjects or patients with type 2 diabetes for over 5 years and collected information on cardiovascular risk factors. Fasting blood samples and urine were collected and biomarkers of B-vitamins were measured and were related to renal function or to global cardiovascular risk. Global cardiovascular risk was calculated from established models that include Routine clinical and laboratory markers such as plasma lipids, smoking, hypertension, and BMI.

we measured the following markers: Glucose (fasting plasma glucose); HbA1C; serum creatinine; Glomerular filtration rate (GFR), urinary Albumin, C-reactive Protein, Soluble vascular cell adhesion molecule 1 (sVCAM-1), cystatin C, vitamin B1, vitamin B12, holotranscobalamin, methylmalonic acid, homocysteine, and different vitamin B6 forms.


Recruitment information / eligibility

Status Completed
Enrollment 174
Est. completion date September 2011
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

1. Written informed consent before any study-related activities

2. Ambulatory subject >18 years of age

For patients with type 2 Diabetes:

3. Duration of diabetes = 5 years

4. Glycated haemoglobin (HbA1C) <10%

5. Body mass index (BMI) 19-40 kg/m2

For healthy controls:

6. No diabetes (normal fasting glucose levels measured by stick)

Exclusion Criteria:

1. End stage renal disease (creatinine clearance <10 mL/min)

2. Severe excess alcohol consumption (>50 units/week)

3. Severe co-morbidities

4. Renal and/or pancreatic transplant

5. Vitamin B1, B6 and/or B12 substitution (incl. multivitamin preparations)

6. Participation in an interventional study within 30 previous days;

7. Patient is female and pregnant or lactating

8. Patient is female in a childbearing age without adequate contraceptive precaution

Study Design


Intervention

Other:
Type 2 diabetes
Test if patients with diabetes have different blood concentrations of vitamin biomarkers compared with control subjects and if vitamin levels in the patients will differ according to renal damage.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Rima Obeid Merck KGaA, Syneed Medidata GmbH

References & Publications (1)

Nix WA, Zirwes R, Bangert V, Kaiser RP, Schilling M, Hostalek U, Obeid R. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract. 2015 Jan;107(1):157-65. doi: 10.1016/j.diabres.2014.09.05 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The difference in serum vitamin B12 levels between cases and controls Compare mean levels of the controls with those in the patients Baseline
Primary The difference in serum vitamin B1 between cases and controls Compare mean levels of the controls with those in the patients Baseline
Primary The difference in serum vitamin B6 concentrations between cases and controls Compare mean levels of the controls with those in the patients Baseline
Secondary The difference in serum vitamin B12 between patients with and those without albuminuria Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria Baseline
Secondary The difference in serum and urine vitamin B1 between patients with and those without albuminuria Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria Baseline
Secondary The difference in serum and urine vitamin B6 vitamers between patients with and those without albuminuria Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria Baseline
Secondary The difference in serum and urine vitamin B6 vitamers between patients with advanced global vascular risk versus those with a low vascular risk Compare mean levels of diabetes patients with microalbuminuria and those without microalbuminuria Baseline
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2

External Links